PMGC Holdings ELAB Peer Comparison

NASDAQ ELAB
$4.62 +0.00 (+0.00%)
As of: Sep 10, 2026 · 9:30 AM EDT
Peer Comparison

300 Comparable Companies

Industry Biotechnology

The table below compares all 300 Biotechnology companies on 8 financial metrics.

Download Data
# Ticker Company match industry_code industry_group industry_group_code Market Capitalization P/E P/S Enterprise Value
1 AMGN Amgen Inc primary H-02 Pharmaceuticals and Biotechnology HG-01 211.28 Bn 24.17 5.55 197.29 Bn
2 GILD Gilead Sciences, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 180.97 Bn -62.51 5.94 177.80 Bn
3 VRTX Vertex Pharmaceuticals Inc / Ma primary H-02 Pharmaceuticals and Biotechnology HG-01 132.56 Bn 30.09 10.53 124.70 Bn
4 REGN Regeneron Pharmaceuticals, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 82.34 Bn 19.02 5.30 74.34 Bn
5 ARGX Argenx Se primary H-02 Pharmaceuticals and Biotechnology HG-01 60.73 Bn 35.41 11.62 55.54 Bn
6 MRNA Moderna, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 52.08 Bn -16.53 23.38 46.95 Bn
7 ALNY Alnylam Pharmaceuticals, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 33.90 Bn 43.75 7.06 30.59 Bn
8 BIIB Biogen Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 31.21 Bn 37.40 3.11 29.93 Bn
9 ROIV Roivant Sciences Ltd. primary H-02 Pharmaceuticals and Biotechnology HG-01 29.68 Bn -20.00 2,717.35 29.68 Bn
10 INSM INSMED Inc primary H-02 Pharmaceuticals and Biotechnology HG-01 27.22 Bn -31.09 23.92 26.06 Bn
11 BNTX BioNTech SE primary H-02 Pharmaceuticals and Biotechnology HG-01 23.39 Bn -13.73 7.56 9.74 Bn
12 ASND Ascendis Pharma A/S primary H-02 Pharmaceuticals and Biotechnology HG-01 15.81 Bn 18.23 11.15 14.86 Bn
13 MDGL Madrigal Pharmaceuticals, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 15.80 Bn -49.54 12.31 14.97 Bn
14 BBIO BridgeBio Pharma, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 14.78 Bn -21.36 20.72 14.06 Bn
15 SMMT Summit Therapeutics Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 13.39 Bn — — 12.70 Bn
16 HALO Halozyme Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 12.55 Bn 30.34 7.54 12.32 Bn
17 BMRN Biomarin Pharmaceutical Inc primary H-02 Pharmaceuticals and Biotechnology HG-01 12.38 Bn 169.67 3.63 11.51 Bn
18 ARWR Arrowhead Pharmaceuticals, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 11.63 Bn -42.74 17.37 10.03 Bn
19 AAVXF Abivax S.A. primary H-02 Pharmaceuticals and Biotechnology HG-01 10.92 Bn -25.97 — 10.92 Bn
20 APGE Apogee Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 10.18 Bn -34.62 — 9.20 Bn
21 PRAX Praxis Precision Medicines, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 9.88 Bn -25.90 — 9.12 Bn
22 PTGX Protagonist Therapeutics, Inc primary H-02 Pharmaceuticals and Biotechnology HG-01 9.45 Bn 85.62 33.53 9.45 Bn
23 IONS Ionis Pharmaceuticals Inc primary H-02 Pharmaceuticals and Biotechnology HG-01 9.15 Bn -43.10 10.47 7.09 Bn
24 PCVX Vaxcyte, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 8.61 Bn -8.14 — 8.61 Bn
25 IBRX ImmunityBio, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 8.22 Bn -8.28 49.59 7.86 Bn
26 IMVT Immunovant, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 7.79 Bn -14.47 — 7.79 Bn
27 TGTX Tg Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 7.69 Bn 17.40 9.61 7.01 Bn
28 GIFLF Grifols SA primary H-02 Pharmaceuticals and Biotechnology HG-01 7.54 Bn 29.70 0.46 9.09 Bn
29 SYRE Spyre Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 7.24 Bn -40.45 — 7.24 Bn
30 SRRK Scholar Rock Holding Corp primary H-02 Pharmaceuticals and Biotechnology HG-01 7.04 Bn -17.45 — 7.04 Bn
31 RYTM Rhythm Pharmaceuticals, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 6.96 Bn -33.12 29.02 6.63 Bn
32 BLRX BioLineRx Ltd. primary H-02 Pharmaceuticals and Biotechnology HG-01 6.48 Bn -723.95 4,657.81 6.48 Bn
33 CGON CG Oncology, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 6.24 Bn -27.86 1,002.66 6.24 Bn
34 MIRM Mirum Pharmaceuticals, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 6.19 Bn -7.19 10.01 5.75 Bn
35 KNSA Kiniksa Pharmaceuticals International, plc primary H-02 Pharmaceuticals and Biotechnology HG-01 6.08 Bn 75.43 7.24 5.56 Bn
36 DBVT DBV Technologies S.A. primary H-02 Pharmaceuticals and Biotechnology HG-01 5.82 Bn -33.06 1,159.20 5.64 Bn
37 XENE Xenon Pharmaceuticals Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 5.80 Bn -16.00 — 5.80 Bn
38 COGT Cogent Biosciences, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 5.75 Bn -15.55 — 5.75 Bn
39 LGND Ligand Pharmaceuticals Inc primary H-02 Pharmaceuticals and Biotechnology HG-01 5.68 Bn 28.82 19.57 4.33 Bn
40 ORKA Oruka Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 5.62 Bn — — 3.89 Bn
41 PTCT Ptc Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 5.57 Bn 14.55 5.52 3.34 Bn
42 ERAS Erasca, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 4.83 Bn -16.82 — 4.83 Bn
43 CELC Celcuity Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 4.83 Bn -22.04 — 4.83 Bn
44 DNLI Denali Therapeutics Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 3.98 Bn -7.78 1,103.41 3.98 Bn
45 DNTH Dianthus Therapeutics, Inc. /DE/ primary H-02 Pharmaceuticals and Biotechnology HG-01 3.95 Bn — — 3.54 Bn
46 VKTX Viking Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 3.75 Bn -7.00 — 3.75 Bn
47 TLPPF Telix Pharmaceuticals Ltd primary H-02 Pharmaceuticals and Biotechnology HG-01 3.72 Bn -521.64 4.64 3.43 Bn
48 RLAY Relay Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 3.72 Bn -13.00 359.05 3.72 Bn
49 AMLX Amylyx Pharmaceuticals, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 3.52 Bn -28.95 — 3.52 Bn
50 TNGX Tango Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 3.51 Bn -34.33 65.30 2.50 Bn
51 RCUS Arcus Biosciences, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 3.50 Bn -7.61 29.91 2.80 Bn
52 IDYA IDEAYA Biosciences, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 3.46 Bn -15.73 14.79 2.63 Bn
53 ABCL AbCellera Biologics Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 3.27 Bn -19.87 49.45 3.27 Bn
54 DYN Dyne Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 3.09 Bn -5.98 — 3.09 Bn
55 ARQT Arcutis Biotherapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 3.09 Bn 108.28 6.65 2.85 Bn
56 CLDX Celldex Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 2.97 Bn -9.66 18,802.30 2.97 Bn
57 MBX MBX Biosciences, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 2.96 Bn -28.40 — 2.96 Bn
58 IRON Disc Medicine, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 2.90 Bn -14.42 — 2.90 Bn
59 IMNM Immunome Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 2.90 Bn -10.74 593.06 2.38 Bn
60 NRIX Nurix Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 2.85 Bn -8.36 77.62 2.41 Bn
61 ZLAB Zai Lab Ltd primary H-02 Pharmaceuticals and Biotechnology HG-01 2.66 Bn -14.16 5.93 1.96 Bn
62 SLS SELLAS Life Sciences Group, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 2.58 Bn -79.44 — 2.58 Bn
63 OCUL Ocular Therapeutix, Inc primary H-02 Pharmaceuticals and Biotechnology HG-01 2.52 Bn -8.33 48.44 2.52 Bn
64 VERA Vera Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 2.43 Bn -6.08 — 2.43 Bn
65 XTLB Xtl Biopharmaceuticals Ltd primary H-02 Pharmaceuticals and Biotechnology HG-01 2.38 Bn -2,975.41 — 2.38 Bn
66 NKTR Nektar Therapeutics primary H-02 Pharmaceuticals and Biotechnology HG-01 2.37 Bn -19.93 43.38 1.68 Bn
67 VRDN Viridian Therapeutics, Inc.\DE primary H-02 Pharmaceuticals and Biotechnology HG-01 2.32 Bn -5.81 32.67 2.32 Bn
68 PHVS Pharvaris N.V. primary H-02 Pharmaceuticals and Biotechnology HG-01 2.23 Bn -11.24 — 1.86 Bn
69 URGN UroGen Pharma Ltd. primary H-02 Pharmaceuticals and Biotechnology HG-01 2.23 Bn -35.77 11.80 2.12 Bn
70 ADMA Adma Biologics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 2.13 Bn 12.83 4.17 2.00 Bn
71 BCRX Biocryst Pharmaceuticals Inc primary H-02 Pharmaceuticals and Biotechnology HG-01 2.12 Bn -5.52 3.97 1.77 Bn
72 GMAB Genmab A/S primary H-02 Pharmaceuticals and Biotechnology HG-01 2.10 Bn 0.17 0.33 0.59 Bn
73 RAPP Rapport Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 2.09 Bn -15.23 104.43 2.09 Bn
74 BHVN Biohaven Ltd. primary H-02 Pharmaceuticals and Biotechnology HG-01 2.06 Bn -3.52 — 1.80 Bn
75 KOD Kodiak Sciences Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 2.06 Bn -8.53 — 2.06 Bn
76 AGIO Agios Pharmaceuticals, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 2.00 Bn -4.87 20.37 2.00 Bn
77 CMPS COMPASS Pathways plc primary H-02 Pharmaceuticals and Biotechnology HG-01 1.98 Bn -5.03 — 1.98 Bn
78 ZBIO Zenas BioPharma, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 1.97 Bn -4.74 1,972.88 1.97 Bn
79 STOK Stoke Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 1.94 Bn -9.35 70.44 1.65 Bn
80 ZYME Zymeworks Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 1.94 Bn -12.95 52.34 1.67 Bn
81 XNCR Xencor Inc primary H-02 Pharmaceuticals and Biotechnology HG-01 1.82 Bn -11.13 17.31 1.44 Bn
82 VIR Vir Biotechnology, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 1.76 Bn -6.99 5.80 1.76 Bn
83 IMCR Immunocore Holdings plc primary H-02 Pharmaceuticals and Biotechnology HG-01 1.75 Bn -96.77 4.07 0.87 Bn
84 SNDX Syndax Pharmaceuticals Inc primary H-02 Pharmaceuticals and Biotechnology HG-01 1.74 Bn -9.60 6.90 1.19 Bn
85 GLPGF Lakefront Biotherapeutics NV primary H-02 Pharmaceuticals and Biotechnology HG-01 1.73 Bn 0.00 1.50 1.73 Bn
86 INBX Inhibrx Biosciences, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 1.71 Bn -12.83 1,316.56 1.71 Bn
87 SEPN Septerna, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 1.70 Bn -121.70 17.18 1.70 Bn
88 RXRX Recursion Pharmaceuticals, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 1.67 Bn -3.21 30.38 1.12 Bn
89 GHRS GH Research PLC primary H-02 Pharmaceuticals and Biotechnology HG-01 1.66 Bn -26.72 — 1.30 Bn
90 ATAI AtaiBeckley Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 1.59 Bn -10.36 525.18 1.59 Bn
91 FBRX Forte Biosciences, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 1.58 Bn -20.71 — 1.23 Bn
92 ANAB Anaptysbio, Inc primary H-02 Pharmaceuticals and Biotechnology HG-01 1.58 Bn -66.03 7.92 1.29 Bn
93 DMRA Damora Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 1.57 Bn -5.96 — 1.03 Bn
94 BCAX Bicara Therapeutics Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 1.57 Bn -8.45 — 1.57 Bn
95 SCNI Scinai Immunotherapeutics Ltd. primary H-02 Pharmaceuticals and Biotechnology HG-01 1.54 Bn -183.98 894.90 1.54 Bn
96 NVAX Novavax Inc primary H-02 Pharmaceuticals and Biotechnology HG-01 1.51 Bn -6.08 3.64 0.79 Bn
97 MAZE Maze Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 1.48 Bn -13.97 74.10 1.48 Bn
98 AAPG Ascentage Pharma Group International primary H-02 Pharmaceuticals and Biotechnology HG-01 1.48 Bn -9.11 20.12 1.20 Bn
99 ANRO Alto Neuroscience, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 1.45 Bn -17.27 — 1.45 Bn
100 RARE Ultragenyx Pharmaceutical Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 1.44 Bn -3.12 2.01 1.15 Bn
101 AVBP ArriVent BioPharma, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 1.42 Bn -8.68 — 1.42 Bn
102 GLUE Monte Rosa Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 1.42 Bn -9.20 49.31 0.78 Bn
103 TYRA Tyra Biosciences, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 1.41 Bn -9.50 — 1.41 Bn
104 OMER Omeros Corp primary H-02 Pharmaceuticals and Biotechnology HG-01 1.38 Bn 80.63 35.82 1.38 Bn
105 REPL Replimune Group, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 1.36 Bn -4.59 — 1.36 Bn
106 SVRA Savara Inc primary H-02 Pharmaceuticals and Biotechnology HG-01 1.33 Bn -9.56 — 1.33 Bn
107 ORIC Oric Pharmaceuticals, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 1.31 Bn -8.35 — 1.31 Bn
108 ALMS Alumis Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 1.31 Bn -5.43 157.88 0.81 Bn
109 ABSI Absci Corp primary H-02 Pharmaceuticals and Biotechnology HG-01 1.31 Bn -10.82 839.31 1.11 Bn
110 CGEM Cullinan Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 1.28 Bn -6.29 — 1.28 Bn
111 VOR Vor Biopharma Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 1.24 Bn -1.35 — 1.24 Bn
112 CRVS Corvus Pharmaceuticals, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 1.20 Bn -25.05 — 0.98 Bn
113 MNKD Mannkind Corp primary H-02 Pharmaceuticals and Biotechnology HG-01 1.19 Bn -27.36 3.03 1.08 Bn
114 JANX Janux Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 1.19 Bn -11.57 49.46 1.19 Bn
115 JBIO Jade Biosciences, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 1.14 Bn -7.43 — 1.14 Bn
116 CLYM Climb Bio, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 1.12 Bn -19.46 — 1.12 Bn
117 ABUS Arbutus Biopharma Corp primary H-02 Pharmaceuticals and Biotechnology HG-01 1.02 Bn 6.67 5.59 0.92 Bn
118 MLTX MoonLake Immunotherapeutics primary H-02 Pharmaceuticals and Biotechnology HG-01 1.00 Bn -3.77 — 0.46 Bn
119 OKYO OKYO Pharma Ltd primary H-02 Pharmaceuticals and Biotechnology HG-01 0.97 Bn -118.02 — 0.97 Bn
120 WVE Wave Life Sciences, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.95 Bn -4.72 14.61 0.59 Bn
121 ARDX Ardelyx, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.93 Bn -16.72 2.07 0.65 Bn
122 MNPR Monopar Therapeutics primary H-02 Pharmaceuticals and Biotechnology HG-01 0.93 Bn -67.07 — 0.88 Bn
123 GERN Geron Corp primary H-02 Pharmaceuticals and Biotechnology HG-01 0.92 Bn -13.74 3.79 0.62 Bn
124 TBPH Theravance Biopharma, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.88 Bn 20.77 8.42 0.49 Bn
125 RIGL Rigel Pharmaceuticals Inc primary H-02 Pharmaceuticals and Biotechnology HG-01 0.87 Bn 2.70 3.14 0.77 Bn
126 ANNX Annexon, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.85 Bn -4.15 — 0.85 Bn
127 STTK Shattuck Labs, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.80 Bn -14.86 802.04 0.80 Bn
128 AVTX Avalo Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.78 Bn -7.74 — 0.78 Bn
129 ACRS Aclaris Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.77 Bn -9.69 93.85 0.77 Bn
130 CTMX CytomX Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.76 Bn -10.05 41.63 0.43 Bn
131 PHAR Pharming Group N.V. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.75 Bn -120.18 2.24 0.59 Bn
132 ZURA Zura Bio Ltd primary H-02 Pharmaceuticals and Biotechnology HG-01 0.72 Bn -6.14 — 0.72 Bn
133 AURA Aura Biosciences, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.67 Bn -6.15 — 0.61 Bn
134 IRWD Ironwood Pharmaceuticals Inc primary H-02 Pharmaceuticals and Biotechnology HG-01 0.65 Bn 2.95 1.68 0.57 Bn
135 SLN Silence Therapeutics plc primary H-02 Pharmaceuticals and Biotechnology HG-01 0.62 Bn -16.07 1,015.39 0.55 Bn
136 ALT Altimmune, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.61 Bn -8.32 — 0.61 Bn
137 ASMB Assembly Biosciences, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.60 Bn 482.40 8.02 0.28 Bn
138 CBIO Crescent Biopharma, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.59 Bn -3.62 568.62 0.42 Bn
139 OCS Oculis Holding AG primary H-02 Pharmaceuticals and Biotechnology HG-01 0.59 Bn -336,183.16 — 0.59 Bn
140 TECX Tectonic Therapeutic, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.57 Bn -6.70 — 0.57 Bn
141 SGMT Sagimet Biosciences Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.57 Bn -11.90 — 0.57 Bn
142 CTNM Contineum Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.56 Bn -9.28 — 0.56 Bn
143 VALN Valneva SE primary H-02 Pharmaceuticals and Biotechnology HG-01 0.56 Bn -9.58 3.35 0.42 Bn
144 ARVN Arvinas, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.55 Bn 59.43 1.75 -0.02 Bn
145 BBOT BridgeBio Oncology Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.51 Bn -2.57 — 0.29 Bn
146 IMUX Immunic, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.51 Bn -4.43 — 0.51 Bn
147 OABI OmniAb, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.51 Bn -11.49 13.23 0.46 Bn
148 ANL Adlai Nortye Ltd. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.49 Bn -10.27 78.36 0.26 Bn
149 PRLD Prelude Therapeutics Inc primary H-02 Pharmaceuticals and Biotechnology HG-01 0.49 Bn -7.23 21.72 0.21 Bn
150 PRTA Prothena Corp Public Ltd Co primary H-02 Pharmaceuticals and Biotechnology HG-01 0.48 Bn -10.86 8.75 0.19 Bn
151 NEUP Neuphoria Therapeutics Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.47 Bn -19.83 — 0.45 Bn
152 KMDA Kamada Ltd primary H-02 Pharmaceuticals and Biotechnology HG-01 0.47 Bn 15.03 2.44 0.40 Bn
153 RLMD Relmada Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.46 Bn -7.51 — 0.46 Bn
154 PBYI Puma Biotechnology, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.45 Bn 15.17 1.97 0.36 Bn
155 DRUG Bright Minds Biosciences Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.44 Bn -15.17 — 0.44 Bn
156 CCCC C4 Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.44 Bn -4.32 12.50 0.18 Bn
157 RZLT Rezolute, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.42 Bn -5.13 — 0.42 Bn
158 AVIR Atea Pharmaceuticals, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.42 Bn -3.04 — 0.42 Bn
159 BIOA BioAge Labs, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.40 Bn -4.28 38.79 0.40 Bn
160 CMPX Compass Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.40 Bn -4.86 — 0.40 Bn
161 LRMR Larimar Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.39 Bn -2.22 — 0.23 Bn
162 EVMN Evommune, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.38 Bn -4.00 37.83 0.18 Bn
163 EYPT EyePoint, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.38 Bn -1.22 135.60 0.20 Bn
164 ENTA Enanta Pharmaceuticals Inc primary H-02 Pharmaceuticals and Biotechnology HG-01 0.38 Bn -5.98 5.79 0.19 Bn
165 HMDCF HUTCHMED (China) Ltd primary H-02 Pharmaceuticals and Biotechnology HG-01 0.38 Bn — — 0.39 Bn
166 ARCT Arcturus Therapeutics Holdings Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.37 Bn -3.92 12.70 0.18 Bn
167 DMAC DiaMedica Therapeutics Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.35 Bn -10.70 — 0.35 Bn
168 CATX Perspective Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.35 Bn -2.92 — 0.35 Bn
169 WHWK Whitehawk Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.34 Bn -4.28 — 0.34 Bn
170 FHTX Foghorn Therapeutics Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.32 Bn -4.95 8.84 0.26 Bn
171 EPRX Eupraxia Pharmaceuticals Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.32 Bn -6.40 — 0.32 Bn
172 UPB Upstream Bio, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.31 Bn -1.96 99.53 0.31 Bn
173 ELDN Eledon Pharmaceuticals, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.31 Bn -3.78 — 0.31 Bn
174 FIXX Q32 Bio Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.30 Bn 64.31 — 0.19 Bn
175 STRO Sutro Biopharma, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.30 Bn -2.61 3.30 0.13 Bn
176 TRDA Entrada Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.30 Bn -1.78 63.07 0.30 Bn
177 EQ Equillium, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.28 Bn -15.76 — 0.28 Bn
178 AGEN Agenus Inc primary H-02 Pharmaceuticals and Biotechnology HG-01 0.28 Bn 3.05 2.11 0.28 Bn
179 ACIU AC Immune SA primary H-02 Pharmaceuticals and Biotechnology HG-01 0.28 Bn -5.08 12.42 0.28 Bn
180 CYDY CytoDyn Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.27 Bn -7.64 — 0.27 Bn
181 BCYC Bicycle Therapeutics Plc primary H-02 Pharmaceuticals and Biotechnology HG-01 0.27 Bn -1.44 4.48 0.27 Bn
182 SABS SAB Biotherapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.27 Bn -3.98 — 0.27 Bn
183 GALT Galectin Therapeutics Inc primary H-02 Pharmaceuticals and Biotechnology HG-01 0.26 Bn -9.24 — 0.26 Bn
184 MGNX Macrogenics Inc primary H-02 Pharmaceuticals and Biotechnology HG-01 0.26 Bn -15.90 1.53 0.14 Bn
185 CAMP Camp4 Therapeutics Corp primary H-02 Pharmaceuticals and Biotechnology HG-01 0.25 Bn -5.01 59.43 0.25 Bn
186 AVXL Anavex Life Sciences Corp. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.25 Bn -17.83 — 0.13 Bn
187 ANTX AN2 Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.25 Bn -6.85 — 0.25 Bn
188 ALXO Alx Oncology Holdings Inc primary H-02 Pharmaceuticals and Biotechnology HG-01 0.25 Bn -3.05 — 0.25 Bn
189 IVVD Invivyd, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.25 Bn -2.92 4.38 0.09 Bn
190 SRZN Surrozen, Inc./DE primary H-02 Pharmaceuticals and Biotechnology HG-01 0.23 Bn -3.81 20.21 0.23 Bn
191 ALEC Alector, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.23 Bn -2.65 16.77 0.06 Bn
192 CGEN Compugen Ltd primary H-02 Pharmaceuticals and Biotechnology HG-01 0.23 Bn 6.48 3.08 0.14 Bn
193 NMRA Neumora Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.22 Bn -1.36 — 0.22 Bn
194 KRRO Korro Bio, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.22 Bn -2.68 92.97 0.11 Bn
195 KROS Keros Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.22 Bn -2.42 6.66 -0.04 Bn
196 PEPG PepGen Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.22 Bn -3.00 — 0.22 Bn
197 PLX Protalix BioTherapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.21 Bn 9.99 2.62 0.17 Bn
198 PYXS Pyxis Oncology, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.21 Bn -3.20 15.26 0.18 Bn
199 GLSI Greenwich LifeSciences, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.21 Bn -9.46 — 0.21 Bn
200 CHRS Coherus Oncology, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.20 Bn -1.53 3.98 0.10 Bn
201 ABOS Acumen Pharmaceuticals, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.20 Bn -1.93 — 0.20 Bn
202 PRQR ProQR Therapeutics N.V. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.20 Bn -4.12 9.46 0.07 Bn
203 ARMP Armata Pharmaceuticals, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.20 Bn -3.21 — 0.18 Bn
204 FTH Faeth Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.20 Bn -1.01 — 0.20 Bn
205 ADAG Adagene Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.20 Bn -13.14 32.66 0.20 Bn
206 ORMP Oramed Pharmaceuticals Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.19 Bn 1.14 — 0.19 Bn
207 CUE Cue Biopharma, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.19 Bn -1.91 8.60 0.18 Bn
208 ADCT ADC Therapeutics SA primary H-02 Pharmaceuticals and Biotechnology HG-01 0.19 Bn -1.29 2.51 -0.03 Bn
209 QNCX Quince Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.18 Bn -2.44 — 0.18 Bn
210 NBP NovaBridge Biosciences primary H-02 Pharmaceuticals and Biotechnology HG-01 0.18 Bn -2.47 — 0.18 Bn
211 MOLN Molecular Partners Ag primary H-02 Pharmaceuticals and Biotechnology HG-01 0.18 Bn -2.51 214.11 0.18 Bn
212 XLO Xilio Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.17 Bn -5.57 2.72 0.04 Bn
213 IPHA Innate Pharma SA primary H-02 Pharmaceuticals and Biotechnology HG-01 0.17 Bn -1.06 60.09 0.17 Bn
214 RANI Rani Therapeutics Holdings, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.16 Bn -4.80 32.35 0.16 Bn
215 MDWD MediWound Ltd. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.15 Bn -4.96 12.98 0.12 Bn
216 NGEN Nervgen Pharma Corp. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.15 Bn -116.03 — 0.15 Bn
217 MIST Milestone Pharmaceuticals Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.15 Bn — — -0.02 Bn
218 OKUR OnKure Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.14 Bn -2.87 — -0.03 Bn
219 ENTX Entera Bio Ltd. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.14 Bn -9.79 — 0.13 Bn
220 MSLE Satellos Bioscience Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.14 Bn -2.56 — 0.14 Bn
221 UNCY Unicycive Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.14 Bn -4.97 — 0.14 Bn
222 IFRX InflaRx N.V. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.14 Bn 0.00 1,724.22 -0.05 Bn
223 SPRB Spruce Biosciences, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.14 Bn -2.79 — 0.14 Bn
224 INDP Indaptus Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.13 Bn -9.03 — 0.12 Bn
225 RFL Rafael Holdings, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.13 Bn -5.01 136.38 0.14 Bn
226 IBIO iBio, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.13 Bn -3.88 1,279.94 0.13 Bn
227 HURA TuHURA Biosciences, Inc./NV primary H-02 Pharmaceuticals and Biotechnology HG-01 0.13 Bn -4.18 — 0.13 Bn
228 NRXP NRX Pharmaceuticals, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.13 Bn -6.05 37.14 0.10 Bn
229 CNTB Connect Biopharma Holdings Ltd primary H-02 Pharmaceuticals and Biotechnology HG-01 0.12 Bn -1.81 42.31 0.12 Bn
230 PMN ProMIS Neurosciences Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.12 Bn -2.93 — 0.07 Bn
231 BDTX Black Diamond Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.12 Bn -2.46 — 0.01 Bn
232 TLSA Tiziana Life Sciences Ltd primary H-02 Pharmaceuticals and Biotechnology HG-01 0.11 Bn -6.55 — 0.11 Bn
233 GNLX GENELUX Corp primary H-02 Pharmaceuticals and Biotechnology HG-01 0.11 Bn -3.31 — 0.11 Bn
234 COYA Coya Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.11 Bn -4.85 13.48 0.06 Bn
235 INO Inovio Pharmaceuticals, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.11 Bn -1.37 — 0.11 Bn
236 CRBP Corbus Pharmaceuticals Holdings, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.11 Bn — — -0.06 Bn
237 PLYX Polaryx Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.10 Bn -9.67 — 0.09 Bn
238 ONCY Oncolytics Biotech Inc primary H-02 Pharmaceuticals and Biotechnology HG-01 0.10 Bn -3.16 — 0.10 Bn
239 CTOR Citius Oncology, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.09 Bn -2.01 60.89 0.09 Bn
240 TLPH Talphera, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.09 Bn -6.42 90,632.28 0.09 Bn
241 RLYB Rallybio Corp primary H-02 Pharmaceuticals and Biotechnology HG-01 0.09 Bn 2.12 139.00 0.09 Bn
242 ALDX Aldeyra Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.09 Bn -3.86 — 0.09 Bn
243 KLRS Kalaris Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.09 Bn -1.82 — 0.09 Bn
244 RVRC Revium Rx. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.09 Bn -118.64 — 0.09 Bn
245 OTLK Outlook Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.09 Bn -1.41 — 0.07 Bn
246 PYPD PolyPid Ltd. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.09 Bn 2.70 — 0.08 Bn
247 KZIA Kazia Therapeutics Ltd primary H-02 Pharmaceuticals and Biotechnology HG-01 0.08 Bn — — 0.08 Bn
248 FBIO Fortress Biotech, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.08 Bn 9.93 1.21 -0.11 Bn
249 ACRV Acrivon Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.08 Bn -1.11 — 0.08 Bn
250 MAIA MAIA Biotechnology, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.08 Bn -3.02 — 0.05 Bn
251 TELO Telomir Pharmaceuticals, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.08 Bn -1.48 — 0.08 Bn
252 ATHE Alterity Therapeutics Ltd primary H-02 Pharmaceuticals and Biotechnology HG-01 0.08 Bn 0.00 — 0.08 Bn
253 GANX Gain Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.07 Bn -4.02 — 0.07 Bn
254 CRDF Cardiff Oncology, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.07 Bn -1.71 120.97 0.07 Bn
255 SPRO Spero Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.07 Bn 11.71 1.44 0.02 Bn
256 DWTX Dogwood Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.07 Bn -1.84 — 0.07 Bn
257 XBIT XBiotech Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.07 Bn -1.60 — 0.07 Bn
258 HRTX Heron Therapeutics, Inc. /De/ primary H-02 Pharmaceuticals and Biotechnology HG-01 0.06 Bn -6.96 0.41 0.02 Bn
259 SCYX Scynexis Inc primary H-02 Pharmaceuticals and Biotechnology HG-01 0.06 Bn -3.22 3.02 -0.06 Bn
260 IBO Impact Biomedical Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.06 Bn -3.04 1,632.72 0.06 Bn
261 ALGS Aligos Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.05 Bn -0.78 14.70 0.02 Bn
262 RNTX Rein Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.05 Bn -1.08 — 0.05 Bn
263 TIL Instil Bio, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.05 Bn -1.27 — 0.05 Bn
264 IMMP IMMUTEP Ltd primary H-02 Pharmaceuticals and Biotechnology HG-01 0.05 Bn -0.42 5.09 0.05 Bn
265 NMAD Nomad Power Solutions, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.05 Bn -7.33 — 0.05 Bn
266 MCRB Seres Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.05 Bn -0.60 26.29 0.05 Bn
267 BDRX Biodexa Pharmaceuticals Plc primary H-02 Pharmaceuticals and Biotechnology HG-01 0.05 Bn -6.38 — 0.04 Bn
268 PTN Palatin Technologies Inc primary H-02 Pharmaceuticals and Biotechnology HG-01 0.05 Bn -7.83 3.81 0.05 Bn
269 ALP Alpha Compute Corp primary H-02 Pharmaceuticals and Biotechnology HG-01 0.05 Bn -0.02 0.19 0.05 Bn
270 HOWL Werewolf Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.05 Bn -1.38 2.22 0.05 Bn
271 EDSA Edesa Biotech, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.05 Bn -4.34 — 0.05 Bn
272 ATYR aTYR PHARMA INC primary H-02 Pharmaceuticals and Biotechnology HG-01 0.05 Bn -0.71 294.15 -0.01 Bn
273 NXTC NextCure, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.04 Bn -0.95 — 0.04 Bn
274 ELTX Elicio Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.04 Bn -1.06 — 0.02 Bn
275 IMA ImageneBio, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.04 Bn — — -0.09 Bn
276 SER Serina Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.04 Bn -1.45 315.10 0.02 Bn
277 APLM Apollomics Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.04 Bn -3.72 4.79 0.04 Bn
278 MREO Mereo BioPharma Group plc primary H-02 Pharmaceuticals and Biotechnology HG-01 0.04 Bn -1.03 78.97 0.04 Bn
279 ATNM Actinium Pharmaceuticals, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.04 Bn 3.45 1.11 0.04 Bn
280 FLNA Filana Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.04 Bn -1.59 — 0.04 Bn
281 KAPA Kairos Pharma, LTD. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.04 Bn -6.19 0.38 0.03 Bn
282 LITS Lite Strategy, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.04 Bn -0.65 — 0.03 Bn
283 KYNB Kyntra Bio, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.03 Bn 0.18 4.58 0.06 Bn
284 CNTX Context Therapeutics Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.03 Bn -0.75 — 0.03 Bn
285 BETRF BetterLife Pharma Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.03 Bn -21.82 — 0.04 Bn
286 BHST Bioharvest Sciences Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.03 Bn -3.09 0.93 0.02 Bn
287 BRNS Barinthus Biotherapeutics plc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.03 Bn -0.74 — 0.03 Bn
288 TAOX TAO Synergies Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.03 Bn -1.33 38.11 0.03 Bn
289 CLRB Cellectar Biosciences, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.03 Bn -1.24 — 0.03 Bn
290 RAPH Raphael Pharmaceutical Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.03 Bn -23.02 — 0.03 Bn
291 IGC IGC Pharma, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.03 Bn -12.26 93.50 0.03 Bn
292 ADIL Adial Pharmaceuticals, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.03 Bn -0.44 — 0.03 Bn
293 YDESW YD Bio Ltd primary H-02 Pharmaceuticals and Biotechnology HG-01 0.03 Bn — — 0.02 Bn
294 ABVC Abvc Biopharma, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.02 Bn -3.49 — 0.02 Bn
295 RDPTF Radiopharm Theranostics Ltd primary H-02 Pharmaceuticals and Biotechnology HG-01 0.02 Bn -0.28 97.58 0.02 Bn
296 VRXA Veraxa Biotech AG - Post de-SPAC primary H-02 Pharmaceuticals and Biotechnology HG-01 0.02 Bn -0.30 869.19 0.02 Bn
297 NNVC Nanoviricides, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.02 Bn -2.75 — 0.02 Bn
298 LTRN Lantern Pharma Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.02 Bn -1.43 — 0.02 Bn
299 EVAX Evaxion A/S primary H-02 Pharmaceuticals and Biotechnology HG-01 0.02 Bn -2.44 2.81 0.01 Bn
300 JSPR Jasper Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.02 Bn -0.10 — 0.02 Bn